Quanterix (QTRX) Cash from Investing Activities (2017 - 2026)

Quanterix (QTRX) posted Cash from Investing Activities of $25.3 million for Q1 2026, up 199.36% on a QoQ basis from $8.4 million in Q4 2025, and down 22.89% year-over-year from $32.8 million in Q1 2025.

Quanterix (QTRX) Cash from Investing Activities (2017 - 2026) Analysis & Trends

Quanterix's Cash from Investing Activities history runs 10 years deep, the most recent figure standing at $25.3 million for Q1 2026.

  • Quarterly Cash from Investing Activities fell 22.89% year-over-year to $25.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $42.7 million (down 28.41% YoY) and the FY2025 annual result came in at $50.2 million, up 161.06% from the prior year.
  • Cash from Investing Activities was $25.3 million for Q1 2026 at Quanterix, up from $8.4 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $61.9 million in Q2 2025 and bottomed at -$126.1 million in Q3 2023.
  • A 5-year average of -$9.8 million and a median of -$815000.0 in 2022 frame the typical range for Cash from Investing Activities.
  • Peak annual rise in Cash from Investing Activities reached 960.05% in 2024, while the deepest fall reached 80190.44% in 2024.
  • Quanterix's Cash from Investing Activities stood at -$1.6 million in 2022, then tumbled by 1240.19% to -$21.4 million in 2023, then soared by 251.5% to $32.4 million in 2024, then slumped by 73.94% to $8.4 million in 2025, then jumped by 199.36% to $25.3 million in 2026.
  • Business Quant data shows QTRX's Cash from Investing Activities at $25.3 million in Q1 2026, $8.4 million in Q4 2025, and -$52.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 184.15 Bn 176.85 Bn 6.27 Bn -20.32 Bn
2 Stryker 128.85 Bn 125.98 Bn 3.81 Bn -185.00 Mn
3 Medtronic 108.75 Bn 99.53 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 68.66 Bn 67.21 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 48.24 Bn 44.57 Bn 1.29 Bn -92.80 Mn
6 Dexcom 28.42 Bn 27.30 Bn 750.30 Mn -298.50 Mn
7 GE HealthCare Technologies 28.32 Bn 26.03 Bn 1.98 Bn -2.50 Bn
8 Smith & Nephew 26.93 Bn 26.35 Bn - -
9 Koninklijke Philips 25.31 Bn 22.18 Bn 2.07 Bn -475.32 Mn
10 Quanterix 175.00 Mn 75.73 Mn 15.57 Mn 25.26 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 25.26 Mn
Mar 31, 2026 25.26 Mn
Dec 31, 2025 8.44 Mn
Dec 31, 2025 8.44 Mn
Sep 30, 2025 -52.85 Mn
Sep 30, 2025 -52.85 Mn
Jun 30, 2025 61.88 Mn
Jun 30, 2025 61.88 Mn
Mar 31, 2025 32.76 Mn
Mar 31, 2025 32.76 Mn
Dec 31, 2024 32.38 Mn
Dec 31, 2024 32.38 Mn
Sep 30, 2024 -12.43 Mn
Sep 30, 2024 -12.43 Mn
Jun 30, 2024 6.98 Mn
Jun 30, 2024 6.98 Mn
Mar 31, 2024 -109.20 Mn
Mar 31, 2024 -109.20 Mn
Dec 31, 2023 -21.38 Mn
Dec 31, 2023 -21.38 Mn